With Corona cases are on the rise in unprecedented manner, the Maharashtra Government is planning to conduct multi-centric trials of convalescent plasma therapy on Covid-19 patients. In this therapy, antibodies from recovered corona patients are used to treat infected one.

Recently the government received permission to go-ahead for the same. Reportedly, the therapy will be conducted at 21 medical colleges across the State on serious COVID-19 patients, a HT report said.

“There is no ongoing trial for serious patients. The state medical education department has decided to sponsor multi-centric trials for serious patients. Around 21 medical colleges have been shortlisted,” Sanjay Mukherjee, secretary, medical education department was quoted as saying by the report.

“The Drug Controller General of India has approved it. This would be the largest trial in the world for the use of convalescent plasma as therapy for severe patients. If it is successful, plasma therapy will become standard practice in treatment of severe patients.”

Also read: How COVID-19 has Taken Toll on Financial Health of Hospital Business

With 2,786 Covid-19 cases reported on Monday, the total tally of positive cases in the State have mounted to 1.10 lakh. The death toll now stands at 4,128.

“We will be building a facility to conduct the trials at the colleges. It means infrastructure will also be created there, which will come as another advantage for the state,” said Mukherjee. “We are all excited as it is happening in the country for the first time.”

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.